Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy

详细信息    查看全文

• 作者：Tomohiro Sakashita^a ; ^{t-sakashita@med.hokudai.ac.jp" class="auth_mail} ; Akihiro Homma^a ; ^{ak-homma@med.hokudai.ac.jp" class="auth_mail} ; Hiromitsu Hatakeyama^a ; ^{htkym@med.hokudai.ac.jp" class="auth_mail} ; Satoshi Kano^a ; ^{skano@med.hokudai.ac.jp" class="auth_mail} ; Takatsugu Mizumachi^a ; ^{mizumati@med.hokudai.ac.jp" class="auth_mail} ; Jun Furusawa^a ; ^{jfuru@med.hokudai.ac.jp" class="auth_mail} ; Daisuke Yoshida^b ; ^{panacea-hok@umin.net" class="auth_mail} ; Noriyuki Fujima^b ; ^{Noriyuki.Fujima@mb9.seikyou.ne.jp" class="auth_mail} ; Rikiya Onimaru^b ; ^{ronimaru@pop.med.hokudai.ac.jp" class="auth_mail} ; Kazuhiko Tsuchiya^b ; ^{tsuchi1205@gmail.com" class="auth_mail} ; Koichi Yasuda^b ; ^{kyasuda@med.hokudai.ac.jp" class="auth_mail} ; Hiroki Shirato^b ; ^{shirato@med.hokudai.ac.jp" class="auth_mail} ; Fumiyuki Suzuki^c ; ^{fumisuke@hok-mc.hosp.go.jp" class="auth_mail} ; Satoshi Fukuda^a ; ^{safukuda@med.hokudai.ac.jp" class="auth_mail}
• 关键词：Maxillary sinus cancer ; Salvage surgery ; Squamous cell carcinoma ; Chemotherapy ; Radiotherapy ; Intra-arterial
• 刊名：British Journal of Oral and Maxillofacial Surgery
• 出版年：April, 2014
• 年：2014
• 卷：52
• 期：4
• 页码：323-328
• 全文大小：401 K

文摘

Our aim was to evaluate the feasibility of salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy. We retrospectively analysed the records of 61 patients with cancer of the maxillary sinus who were treated in this way. Chemotherapy comprised 100-120 mg/m² superselective intra-arterial infusions of cisplatin given a median of 4 times weekly (range 2-5). Concurrent radiotherapy was given in a median dose of 65 Gy (range 24-70 Gy). Persistent or recurrent cancer of the maxillary sinus was found in 17 patients, of whom 11 had salvage surgery. The disease was controlled in 8 of the 11, and 7 of the 11 survived with no evidence of disease. Their 5-year overall survival was 61%. Two of the 11 developed serious operative complications. Salvage surgery for patients with persistent or recurrent cancer of the maxillary sinus treated by superselective chemoradiotherapy is both safe and successful. Salvage surgery is a good option when this sort of persistent or recurrent cancer is followed up after the regimen of chemoradiotherapy described.